Objectives: To determine whether the duration of antibiotic prophylaxis influences the rate of surgical site infection in patients undergoing coronary bypass grafting or valve replacement.
Introduction
Infectious complications are a major source of morbidity and mortality in patients undergoing cardiac surgery. The incidence of infection at the surgical sites, chest and leg, ranges from ,1% to .10% and increases according to the severity of underlying disease. 1 Routine administration of prophylactic antibiotics to patients undergoing cardiac surgery is a well-accepted tenet of contemporary practice; however, the duration for which the antibiotics should be administered is far from settled. 1 -4 The National Nosocomial Infections Surveillance (NNIS) system, USA, defines surgical site infection as infection occurring within 30 days of surgery and stratifies the risk into four categories based on three parameters: the American Society of Anesthesiologists score, the type of surgery (clean or contaminated) and whether duration of surgery is prolonged (.5 h for cardiac surgery). 4, 5 For most elective cardiac surgery procedures, the American Society of Anesthesiologists score is three and the surgery is clean. Hence, the predicted NNIS incidence of surgical site infection is dependent only on the duration of surgery, which indicates whether it is .5 h. Recently published NNIS data suggest that the risk of infection by 30 days would be 3.5% for operations lasting ,5 h and 5.5% for operations lasting .5 h.
Large studies focusing on cardiac surgery have established that the incidence and risk of surgical site infections are associated with a number of patient-related and procedure-related factors. Furthermore, these risk factors are not merely additive, but are multiplied and surgical site infection may present up to 90 days following cardiac surgery rather than the 30 day limit as suggested by the CDC.
Keeping the above facts in mind, we formulated the present study to compare surgical site wound infection with use of the same antibiotic regimen but differing in duration in patients undergoing coronary artery bypass grafting (CABG) and valve surgery. Another objective was to analyse the risk factors contributing to these events during the study period.
Patients and methods

Setting
Tertiary healthcare centre.
Study population
Patients who underwent CABG or valve replacement under cardiopulmonary bypass between April 2007 and April 2008 were enrolled in this prospective randomized double blind study. After approval of the study protocol by the Institutional Ethics Committee a total of 247 cases were assessed for eligibility criteria; out of them 235 patients were randomly allocated to two groups using a random number table to receive prophylactic antibiotics for a fixed period of time (48 h group, n¼125; 72 h group, n¼110). All patients or their authorized representatives provided written informed consent. The random number table was prepared in the operating room by a person who was not a participant in the study and it was concealed until all cases were over and taken for analysis. The study drugs were administered and clinical data were collected by staff nurses in the cardiac surgical intensive care unit (ICU) who were again blinded regarding the research. The data collection was conducted at the Department of Cardiac Anaesthesia and the Department of Microbiology in the hospital.
Patients≤ 18 years, with pre-existing infection, on mechanical ventilation, with low cardiac output state, with history of allergy to the antibiotics to be used in the trial (ceftazidime pentahydrate and amikacin sulphate), with deranged renal parameters and needing continuation of antibiotics beyond 72 h after surgery were excluded from the study protocol. Per protocol analysis was not applied for the patients who developed post-operative complications other than primary outcome, violated the study protocol and needed either discontinuation of the study regimen or addition of other antibiotics.
Study design
Based on a small study result (carried out by the authors) based on 15 patients in each group the surgical site infection rate was found to be 2% in the 72 h group and 7% in the 48 h group. Assuming a 5% level of significance and 80% power the estimated sample size was 308 patients per group.
Intervention
Patients were shaved the night before surgery and given a scrub bath with chlorhexidine. In the operating room, skin was painted with povidone iodine for 5 min. All patients were operated on by the same surgical team. The practice was of non-usage of bone wax and minimum administration of blood products. The same protocols of skin preparation were used for all patients. None of the patients received topical antibiotics at the time of surgical wound closure. The wounds were painted with povidone iodine ointment and covered with a sterile dressing. Per study protocol, blood chemistries, complete blood counts and serum creatinine were obtained pre-operatively and every alternate day. No routine nasal swab or urine cultures were taken.
All the patients received intravenous ceftazidime pentahydrate and intravenous amikacin sulphate injection at the time of anaesthesia induction and a second dose was given when the duration of surgery exceeded 5 h. The study had two arms: one group received prophylactic antibiotics for 48 h; the other group received prophylactic antibiotics for 72 h. A similar blinded saline bolus was given to patients receiving 48 h of antibiotics for another 24 h. No further intravenous or oral antibiotics were administered.
Assessment
The patients were monitored for surgical site infection and any wound discharge was subjected to Gram's stain and culture. The antibiotic susceptibility of organisms grown was also noted. Any patient having culture-proven wound infection received further antibiotics according to the antibiotic susceptibility of the organism grown. Sternal and leg wounds were inspected daily from the third day onwards and our practice was to keep the wound open and not to apply any topical antibiotics. Patients were followed for 3 months after discharge to look for any late appearance of surgical site infection.
Superficial surgical site infection was defined as infection occurring within 30 days after the operative procedure and involving only skin and subcutaneous tissue of the incision in addition to one of the signs or symptoms of infection with or without purulent discharge from the superficial incision or positive culture of the fluid or tissue from the superficial incision site. 8 Deep surgical site infection was defined as infection involving deep soft tissues and occurring within 30 days after the operative procedure. In addition to these the patient should have had at least one of the following: purulent discharge from the deep incision or spontaneous dehiscence of deep incision or an abscess or other evidence of infection found on direct examination. 8 Sepsis was defined as the presence of whole body inflammatory state in the presence of a known or suspected infection. 9 Any patient having fever in the post-operative period was thoroughly investigated for the possible cause and treated.
Outcome parameters
The primary outcome was the incidence of surgical site infection within the study period. A secondary outcome was development of complications during the course of follow-up for which the study regimen was discontinued and additional antibiotics were needed.
Statistical analysis
All statistical analysis was performed with the Stata 9.0 software package (College Station, TX, USA). Continuous or interval-related variables are expressed as mean+SD. Comparison of continuous variables between groups was done using the Student's t-test. Comparison of discrete variables between groups was done using the x 2 test and Fisher's exact test. A two-sample test of proportion was applied to determine the 95% confidence interval (95% CI) to determine surgical site infection. Independent risk factors for infection were determined using Fisher's exact test. P≤ 0.05 was considered to indicate a statistically significant difference.
Results
Between April 2007 and April 2008, 235 patients were enrolled in the study. See Figure 1 . Six patients from the 48 h group and two from the 72 h group developed severe allergic reactions to the Antibiotic prophylaxis in cardiac surgery skin test and hence were eliminated from receiving the study regimen. A modified treatment analysis was performed for the remaining 227 patients to determine the incidence of surgical site infection. Two patients from the 48 h group and three from the 72 h group discontinued the study regimen due to development of renal failure within 6 h post-operatively. Fifteen patients (13 from the 48 h group and 2 from the 72 h group) had low cardiac output syndrome, prolonged ICU stay and needed prolongation of antibiotic therapy. Four patients from the 48 h group and three from the 72 h group developed ventilator-associated pneumonia requiring additional antibiotics and prolonged mechanical ventilation. All these 27 patients were excluded from the per protocol analysis.
The patients in the two groups were comparable with respect to gender, age, type of surgical procedure, hypertension and anaemia (Table 1 ). The incidence of diabetes mellitus and obesity was higher in the 72 h group (Table 2) . No difference was observed with regard to aortic cross clamp time, cardiopulmonary bypass time, use of blood products, duration of surgery and re-exploration. Use of internal mammary graft was similar in the two groups. The duration of ICU stay and number of cases operated as first case of the day was more in the 48 h group and the 72 h group, respectively (P¼0.008 and 0.008, respectively). The type and incidence of surgical site infection is detailed in Tables 3 and 4 . Twenty patients developed surgical site infections and seven patients developed ventilator-associated pneumonia. In the modified treatment analysis, sternal wound infection occurred in six patients from the 48 h group and eight patients from the 72 h group. This difference was statistically non-significant (P.0.5; Table 3 ). The incidence of donor site infection was 1.68% and 0.84% at Gupta et al.
30 days and 90 days, respectively, in the 48 h group, and 1.85% and 0.98%, respectively, in the 72 h group (Table 3 ). The overall incidence of surgical site infection among the groups was not significant. In a per protocol analysis of 200 patients (100 patients from each group), no statistical difference was observed between the groups regarding the incidence of surgical site infection (P.0.5 in each case; Table 4 ). The overall infection rates were 5% in the group receiving 48 h of prophylactic antibiotic therapy and 8% in the group receiving 72 h of prophylactic antibiotic therapy, and the difference was statistically non-significant (P.0.5). While analysing the various factors that can contribute to sternal wound infection, we found that surgical duration of .5 h (P¼0.034) is an independent risk factor ( Table 5 ). A total of four patients (one from the 48 h group and three from the 72 h group) were found to be culture positive and grew both methicillinsusceptible and methicillin-resistant Staphylococcus, Escherichia coli and coagulase-negative staphylococci. All these organisms were susceptible to both ceftazidime and amikacin except coagulase-negative staphylococci, which were susceptible only to ceftazidime.
Discussion
There is emerging general agreement that post-operative prophylactic antibiotics should be stopped within 24 h of most major surgical procedures. 10 -13 A review of the literature revealed a good correlation between the length of surgical procedure and post-operative infection rate.
14 In general, cardiac surgical procedures routinely require 3 -4 h for completion, thereby placing patients at increased risk of infection. In addition, cardiac surgery patients invariably leave the operating room with indwelling chest catheters and central venous and arterial lines that can be potential routes for bacterial entry and increase the risk of infection. Furthermore, post-operative mediastinitis carries very high hospital mortality and is also associated with reduced long-term survival. 15 Therefore a commonly used JAC approach is to continue antibiotics until invasive lines and chest tubes are in situ. 12 The longer duration of antibiotic use is, however, associated with the risk of drug toxicity, emergence of resistant organisms and increased cost. 16 In the past two decades, the incidence of antimicrobialresistant organisms has increased considerably. In the context of cardiac surgery, antimicrobial resistance essentially refers to the development of cephalosporin-resistant Enterobacteriaceae and vancomycin-resistant enterococci. Several general studies have also suggested some correlation between the prolonged use of post-operative antimicrobial prophylaxis and the development of resistance. 17 -19 Unfortunately these reports are not controlled for specific post-operative time and there is a wide variation in the antibiotics used. Nevertheless there is universal agreement that the longer the duration of an antibiotic regimen, the greater the probability of developing resistant microorganisms. In the present study we did not find a statistically significant difference in surgical site infection and development of resistant microorganisms between groups receiving 48 or 72 h of prophylactic antibiotics. Finkelstein et al. 19 observed that 24 h of cefazolin was more effective than 24 h of vancomycin for cardiac surgical patients in their setting, which had a high prevalence of methicillin-resistant staphylococcal infection. In the study by Finkelstein et al.,
19 a 1.6% rate of major sternal complications was seen in the cefazolin group, indicating that the 24 h cefazolin regimen produced acceptable infection rates in this high-risk population and the researchers concluded that drugs like vancomycin can be reserved for treating proven methicillin-resistant staphylococcal infections.
Kriaras et al. 20 sought to specifically study the optimal duration of prophylactic antibiotics in cardiovascular surgery. A meta-analysis of the trials included seven prophylactic regimens used in 2970 cardiovascular surgery patients. The authors concluded that 'if a cephalosporin is administered properly at the induction of anaesthesia, a low infection rate occurs that cannot be lowered by longer duration of antimicrobial administration'. The major limitation of the study was that it involved seven prophylaxis protocols, five different antibiotics and antibiotic durations of 1, 2 and 4 days in addition to a single-dose arm. 20 The inability to effectively control for this wide array of variables makes it difficult to accept the conclusions drawn by the authors.
In the present study we analysed 11 factors and found that surgery lasting for .5 h is an independent factor predisposing to surgical site infection. We assume that other factors did not reach statistical significance probably due to the small sample size. Unlike previous researchers we did not find obesity to be a predictor for sternal wound infection. 2, 21 This can be explained by the fact that we used the Indian guidelines for defining obesity [body mass index (BMI).25 kg/m 2 ] instead of the WHO guidelines (BMI.30 kg/m 2 ).
22
Unlike previous researchers we did not find any association of diabetes as a contributing factor for sternal wound infection. 23, 24 The use of internal mammary artery has also been implicated as a risk factor for sternal wound infection. 25 -27 We disagree with these investigators and support He et al. 16 who did not find sternal wound infection even after using a bilateral internal mammary graft. Surgical re-exploration has been found to predispose to sternal wound infection, 22 which was not seen in our cases. None of our patients who underwent valvular surgery exhibited sternal wound infection. This could have been due to the younger age of these patients and fewer predisposing factors for wound infection. In four of our patients culture of wound discharge yielded growth of microorganisms. However, none of them exhibited drug-resistant strains. The number of culturepositive wound infections was too small to have any significance regarding emergence of antibiotic resistance. We observed that the day of the week on which surgery was performed was a significant factor predisposing to sternal wound infection. The explanation for this may relate to the fact that the operating rooms are fumigated on a routine basis on Sunday in our centre and, therefore, on Monday the operating room is expected to be the cleanest and least so on Saturday. This factor has not been scrutinized in any of the studies done so far.
Study limitation
To comprehensively prove that the 48 h prophylactic antibiotic regimen is as effective as the longer duration of prophylactic antibiotics, a larger sample size is required. Though the minimum sample size for this test was found to be 308 patients per group, that was not possible during the study period (this study was A. G.'s MCh dissertation and had a time limit of 1 year). The sample size in the study is small and therefore definitive conclusions cannot be drawn from it.
Conclusions
Our study showed that 48 h prophylactic antibiotic therapy using a third-generation cephalosporin and aminoglycoside is at least as effective as a 72 h regimen in relation to surgical site infection. However, further study involving a larger number of patients is needed to emerge with a definite conclusion. The longer duration of antibiotics is not necessary and has the potential of causing an increase in antibiotic resistance and therefore Results are presented as number (%). *Significant.
should be avoided. The optimal duration of prophylactic antibiotics in patients undergoing cardiac surgery is still not defined and further studies in this regard are essential.
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